School of Medicine


Showing 81-100 of 244 Results

  • Zara Patel, MD

    Zara Patel, MD

    Professor of Otolaryngology - Head & Neck Surgery (OHNS)

    BioDr. Zara M. Patel is Director of Endoscopic Skull Base Surgery and a Professor of Otolaryngology and, by courtesy, of Neurosurgery at Stanford. She was born and raised in St. Louis, completed her MD at the Oregon Health and Sciences University in Portland, Oregon and completed her residency training in otolaryngology at Mount Sinai Medical Center in New York, NY. After pursuing fellowship training in rhinology and endoscopic skull base surgery at Stanford University, she was recruited to join the Emory University faculty in Atlanta in 2011. After four years, the rhinology division recruited her back to the West coast to rejoin the department here at Stanford University in 2015.

    Dr. Patel is an expert in advanced endoscopic sinus and skull base surgery. She treats patients with a wide variety of rhinologic complaints, including chronic sinus infection or inflammation, sinus disease that has failed medical therapy, sinus disease that has failed prior surgical therapy, cerebrospinal fluid leaks, benign and and malignant sinus and skull base tumors, as well as olfactory disorders.

    She has served as Chair of the Education Committee and Member of the Board of Directors for the American Rhinologic Society, is current Chair of the Rhinology and Allergy Education Committee for the American Academy of Otolaryngology - Head and Neck Surgery, and has developed a multitude of educational materials for both physicians and patients to help them better understand rhinologic disorders. She is passionate about educating patients to allow them to make the best decisions about their own care, leading to better outcomes.

    Dr. Patel has published widely in topics such as avoiding complications in endoscopic sinus surgery, chronic rhinosinusitis in the immunosuppressed patient population, new devices and techniques for endoscopic skull base surgery, and olfactory dysfunction. She continues to perform research in these areas, and is currently collaborating with neuroscientists and engineers to develop technology that she hopes will eventually help cure patients with smell loss, and potentially even help those with neurodegenerative disorders, such as Alzheimer's and Parkinson's disease.

  • Margot Paul

    Margot Paul

    Clinical Assistant Professor, Psychiatry and Behavioral Sciences

    BioDr. Paul is a Clinical Assistant Professor in the Department of Psychiatry and Behavioral Sciences. She received her undergraduate degree from Tulane University where she graduated magna cum laude with departmental honors in psychology. She then received a master of science degree in behavioral health psychology the following year, after partaking in the 4+1 master's program. She graduated with her doctor of psychology degree from the PGSP-Stanford Psy.D. Consortium, where she won the award for Outstanding Overall Student (2021). She completed her clinical psychology doctoral internship at the Sepulveda VA in Los Angeles and her postdoctoral fellowship in the Department of Psychiatry and Behavioral Sciences at Stanford School of Medicine.

    During her postdoctoral year she continued her research on using virtual reality (VR) as a method of engaging in behavioral activation for individuals with depression. Dr. Paul began her VR work in 2017 after joining Dr. Kim Bullock’s Virtual Reality-Immersive Technology Clinic & Laboratory in the Department of Psychiatry & Behavioral Sciences at Stanford School of Medicine. Dr. Paul won the Cheryl Koopman Dissertation of the Year Award for designing and implementing a feasibility study and three-arm pilot randomized controlled trial to examine the feasibility of using a VR headset as a way to administer behavioral activation therapy for participants with a diagnosis of major depressive disorder. She presented her past and ongoing research findings as a speaker at Shift Medical 2021: Virtual Medical XR Congress and Expo (2021), Stanford Psychiatry Grand Rounds (2022), IVRHA’s 7th Annual Virtual Reality and Healthcare Global Symposium (2023), VMed23 (2023), ADAA (2023), and CYPSY26 (2023). Dr. Paul has worked and consulted with VR companies and local Bay Area startups in the technology and mental health space. She has published on her virtual reality work.

    Clinically, she is interested in working with adults with anxiety and mood disorders, interpersonal difficulties, health-related difficulties, and/or substance use disorders. Dr. Paul has experience working with high-performance individuals, such as healthcare providers and student athletes. She practices using predominantly cognitive behavioral and dialectical behavioral therapies, but integrates various skills depending on the presentation and need of each unique individual.

  • Ria Paul

    Ria Paul

    Clinical Associate Professor, Medicine - Primary Care and Population Health

    BioClinical Focus
    .Internal Medicine
    .Geriatric Medicine
    .Wellness
    .Focus on Health Disparities in Elderly Population

  • Arogyaswami Paulraj

    Arogyaswami Paulraj

    Professor (Research) of Electrical Engineering, Emeritus

    BioProfessor Emeritus Arogyaswami Paulraj, Stanford University, is a pioneer of MIMO wireless communications, a technology break through that enables improved wireless performance. MIMO is now incorporated into all new wireless systems.

    Paulraj is the author of over 400 research papers, two textbooks, and a co-inventor in 80 US patents.

    Paulraj has won over a dozen awards, notably the National Inventors Hall of Fame (USPTO), Marconi Prize and Fellowship, 2014 and the IEEE Alexander Graham Bell Medal, 2011. He is a fellow of eight scientific / engineering national academies including the US, China, India, and Sweden. He is a fellow of IEEE and AAAS.

    In 1999, Paulraj founded Iospan Wireless Inc. - which developed and established MIMO-OFDMA wireless as the core 4G technology. Iospan was acquired by Intel Corporation in 2003. In 2004, he co-founded Beceem Communications Inc. The company became the market leader in 4G-WiMAX semiconductor and was acquired by Broadcom Corp. in 2010. In 2014 he founded Rasa Networks to develop Machine Learning tools for WiFi Networks. The company was acquired HPE in 2016.

    During his 30 years in the Indian (Navy) (1961-1991), he founded three national-level laboratories in India and headed one of India’s most successful military R&D projects – APSOH sonar. He received over a dozen awards (many at the national level) in India including the Padma Bhushan, Ati Vishist Seva Medal and the VASVIK Medal.

  • John M. Pauly

    John M. Pauly

    Reid Weaver Dennis Professor

    BioInterests include medical imaging generally, and magnetic resonance imaging (MRI) in particular. Current efforts are focused on medical applications of MRI where real-time interactive imaging is important. Two examples are cardiac imaging, and the interactive guidance of interventional procedures. Specific interests include rapid methods for the excitation and acquisition of the MR signal, and the reconstruction of images from the data acquired using these approaches.

  • Kim Butts Pauly

    Kim Butts Pauly

    Professor of Radiology (Radiological Sciences Lab) and, by courtesy, of Electrical Engineering and of Bioengineering

    Current Research and Scholarly InterestsWe are investigating and developing, and applying focused ultrasound in neuromodulation, blood brain barrier opening, and ablation for both neuro and body applications.

  • Christopher K. Payne, MD

    Christopher K. Payne, MD

    Professor of Urology at the Stanford University Medical Center, Emeritus

    Current Research and Scholarly InterestsObstetric Fistula Projects:
    1. Preoperative ultrasound evaluation to detect ureteric involvement in vesicovaginal fistulas
    2. Patient narrative study to identify key medical, social and economic factors that lead to fistula formation
    3. Study of urinary continence after fistula repair

    Pelvic pain: investigation into role of pelvic floor in chronic pelvic pain

  • Susan Payrovi

    Susan Payrovi

    Clinical Assistant Professor, Anesthesiology, Perioperative and Pain Medicine

    BioDr. Payrovi is a physician practicing Integrative and Functional Medicine at Stanford’s Center for Integrative Medicine. She earned her bachelor’s degree in Microbiology and Molecular Genetics at UCLA and completed her medical education at UC San Diego in 2003. She completed a residency in Anesthesiology at USC in 2007. Dr. Payrovi is board certified in Anesthesiology, Hospice and Palliative Medicine, as well as Integrative Medicine. She has additional training in Functional Medicine and acupuncture.

  • Ronald Pearl

    Ronald Pearl

    Dr. Richard K. and Erika N. Richards Professor

    Current Research and Scholarly InterestsMechanims (molecular and cellular) of pulmonary hypertension, treatment of pulmonary hypertension, treatment of respiratory failure, treatment of septic shock, hemodynamic monitoring

  • Francis Pearman

    Francis Pearman

    Assistant Professor of Education

    BioFrancis A. Pearman is an Assistant Professor of Education in the Graduate School of Education at Stanford University. His research focuses on how poverty and inequality shape the life chances of children, especially in rapidly changing cities. Pearman holds a Ph.D. and M.Ed. from Vanderbilt University and a B.S. from the University of Virginia.

  • Donna Peehl, PhD

    Donna Peehl, PhD

    Professor (Research) of Urology, Emerita

    Current Research and Scholarly InterestsMy research focuses on the molecular and cellular biology of the human prostate. Developing realistic experimental models is a major goal, and primary cultures of prostatic epithelial and stromal cells are my main model system. Our discoveries are relevant to prevention, detection, diagnosis and treatment of benign and malignant prostatic diseases.

  • Mark Pegram

    Mark Pegram

    Susy Yuan-Huey Hung Professor

    Current Research and Scholarly InterestsMolecular mechanisms of targeted therapy resistance in breast and other cancers